Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature (Q34733613)

4 August 2017

1 reference

title

Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature (English)

1 reference

4 August 2017

Robert M Schainfeld

1

1 reference

4 August 2017

publication date

1 July 2002

1 reference

Catheterization and Cardiovascular Interventions

4 August 2017

published in

1 reference

4 August 2017

volume

56

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

421-431

1 reference

Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization

4 August 2017

cites work

1 reference

Usefulness of cilostazol versus ticlopidine in coronary artery stenting

21 January 2018

1 reference

Comparison of cilostazol versus ticlopidine therapy after stent implantation

21 January 2018

1 reference

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial

21 January 2018

1 reference

Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.

21 January 2018

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

Antithrombotic therapy in peripheral arterial occlusive disease

21 January 2018

1 reference

Endovascular stents and stent-grafts: is heparin coating desirable?

21 January 2018

1 reference

Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery

21 January 2018

1 reference

Adjuvant medical therapy in peripheral bypass surgery

21 January 2018

1 reference

Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.

21 January 2018

1 reference

Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use.

21 January 2018

1 reference

Cilostazol: treatment of intermittent claudication

21 January 2018

1 reference

Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting

21 January 2018

1 reference

Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study

21 January 2018

1 reference

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

21 January 2018

1 reference

Endovascular brachytherapy for peripheral vascular disease

21 January 2018

1 reference

Arterial gene therapy for restenosis

21 January 2018

1 reference

Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy.

21 January 2018

1 reference

Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study)

21 January 2018

1 reference

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries

21 January 2018

1 reference

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C

21 January 2018

1 reference

Effects of perioperative iloprost on patency of femorodistal bypass grafts

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CCD.10211

1 reference

4 August 2017

1 reference